Cargando…
Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents
A 74-years-old male who was a smoker and received treatment for hypertension, dyslipidemia, peripheral arterial disease and idiopathic interstitial pneumonia complained of subcutaneous hemorrhage of the right lower thigh. Marked anemia (hemoglobin 5.5 g/dL) and prolonged activated partial thrombopla...
Autores principales: | Saito, Makoto, Senjo, Hajime, Kanaya, Minoru, Izumiyama, Koh, Mori, Akio, Tanaka, Masanori, Morioka, Masanobu, Ieko, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151351/ https://www.ncbi.nlm.nih.gov/pubmed/30283617 http://dx.doi.org/10.4081/hr.2018.7453 |
Ejemplares similares
-
Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases
por: Saito, Makoto, et al.
Publicado: (2016) -
Acquired hemophilia A in solid cancer: Two case reports and review of the literature
por: Saito, Makoto, et al.
Publicado: (2018) -
Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on (18)F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma
por: Senjo, Hajime, et al.
Publicado: (2019) -
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
por: Kobayashi, Mirei, et al.
Publicado: (2023) -
Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2023)